(Q61914720)
Statements
A Phase 1, Repeated Single-Dose, Double Blind, Randomized, Five Treatment Controlled Safety and Pharmacological Response Evaluation Trial of MKC253 Inhalation Powder in Adult Male and Postmenopausal Female Subjects With Type 2 Diabetes Mellitus (English)
0 references
February 2008
0 references
September 2008
0 references
20
0 references
18 year
0 references
70 year
0 references